You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

I was reminded recently of why I dig mass transit upon overhearing the train conductor and two middle-aged men engaged in a serious talk about mattresses, “trash” 400-thread-counts, and the pros and cons of weighted sheets. Send me your suggestions for a luxurious night’s sleep, and news tips to [email protected] or John_Wilkerson.07 on Signal.

It’s who you know that matters

Sarepta Therapeutics, which has come under regulatory pressure over its gene therapy for Duchenne muscular dystrophy, hired the Trump-connected lobbying firm Michael Best Strategies after the death of a te

See Full Page